CLEVERLEAVES_VER_T-01.jpg
Clever Leaves Reports Third Quarter 2023 Results
November 09, 2023 16:01 ET | Clever Leaves
- Q3 Revenue Increased 33% Year-Over-Year, Propelled by 135% Year-Over-Year Growth in Cannabinoid Revenue, Along with 6% Year-Over-Year Growth in Non-Cannabinoid Revenue - - Q3 Adjusted EBITDA...
CLEVERLEAVES_VER_T-01.jpg
Clever Leaves to Hold Third Quarter 2023 Conference Call on Thursday, November 9, 2023 at 5:00 p.m. ET
November 02, 2023 08:30 ET | Clever Leaves
TOCANCIPÁ, Colombia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, will hold a...
CLEVERLEAVES_VER_T-01.jpg
Clever Leaves Regains Compliance with Nasdaq Minimum Bid Price Requirement
September 13, 2023 08:30 ET | Clever Leaves
TOCANCIPÁ, Colombia, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced that...
CLEVERLEAVES_VER_T-01.jpg
Clever Leaves Cannabis Operations Declared Carbon Neutral; a First for a Vertically Integrated Medicinal Cannabis Company
August 29, 2023 09:00 ET | Clever Leaves
The CO2 Neutrality Certification Reflects Clever Leaves’ Commitment to Environmental Sustainability and long-term vision for the cannabis industry. Sustainable cannabis production has a significant...
CLEVERLEAVES_VER_T-01.jpg
Clever Leaves Announces 1-For-30 Reverse Stock Split to Aid Compliance with Nasdaq Listing Requirements
August 24, 2023 08:00 ET | Clever Leaves
TOCANCIPÁ, Colombia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced that...
CLEVERLEAVES_VER_T-01.jpg
Clever Leaves Reports Second Quarter 2023 Results
August 14, 2023 16:01 ET | Clever Leaves
- Total Revenue Increased 21% Year-Over-Year, Driven by 151% Year-Over-Year Growth in Cannabinoid Revenue - - Continued Expense Reductions Drive Improved Adjusted EBITDA Performance of ($2.1) Million...
CLEVERLEAVES_VER_T-01.jpg
Clever Leaves to Hold Second Quarter 2023 Conference Call on Monday, August 14, 2023 at 5:00 p.m. ET
August 07, 2023 08:30 ET | Clever Leaves
TOCANCIPÁ, Colombia, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, will hold a...
CLEVERLEAVES_VER_T-01.jpg
Colombian Flower Is Now Available To Australian Patients Through Strategic Partnership Between Clever Leaves And Australian Natural Therapeutics Group
July 26, 2023 09:00 ET | Clever Leaves
TOCANCIPÁ, Colombia and SYDNEY, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis...
CLEVERLEAVES_VER_T-01.jpg
Clever Leaves Completes Sale of Processing Assets in Portugal to Curaleaf International Subsidiary
July 05, 2023 08:00 ET | Clever Leaves
TOCANCIPÁ, Colombia, July 05, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced it...
CLEVERLEAVES_VER_T-01.jpg
Clever Leaves and Astrasana Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and Switzerland
May 30, 2023 08:30 ET | Clever Leaves
TOCANCIPÁ, Colombia, May 30, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves”), a global medicinal cannabis company, announced today the arrival of...